Mates Sharon's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Aug 30, 2024
- Accession no.
- 0000950170-24-102475
- Filed
- Aug 30, 2024
- Trade date
- Aug 29-30, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.09M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mates SharonCIK 0001585699 | Director, Officer (Chairman and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2024 | Common Stock | MOption exerciseAcquired | +35,604 | $12.73 | +$453,238.92 | 1,105,933 | Direct | |
| Aug 29, 2024 | Common Stock | SSaleDisposed | −29,832 | $72.44 | −$2,161,030.08 | 1,076,101 | Direct | |
| Aug 29, 2024 | Common Stock | SSaleDisposed | −5,772 | $73.25 | −$422,799 | 1,070,329 | Direct | |
| Aug 30, 2024 | Common Stock | MOption exerciseAcquired | +34,396 | $12.73 | +$437,861.08 | 1,104,725 | Direct | |
| Aug 30, 2024 | Common Stock | SSaleDisposed | −28,203 | $72.73 | −$2,051,204.19 | 1,076,522 | Direct | |
| Aug 30, 2024 | Common Stock | SSaleDisposed | −6,193 | $73.32 | −$454,070.76 | 1,070,329 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2024 | Common Stock | MOption exerciseDisposed | −35,604 | $0.00 | $0 | 137,093 | Direct | |
| Aug 30, 2024 | Common Stock | MOption exerciseDisposed | −34,396 | $0.00 | $0 | 102,697 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.